(Q37700855)
Statements
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules (English)
Qian Liu
Jessica D Sun
Jingli Wang
Dharmendra Ahluwalia
Amanda F Baker
Lee D Cranmer
Damien Ferraro
Yan Wang
Jian-Xin Duan
W Steve Ammons
John G Curd
Mark D Matteucci
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference